| Pronunciation: | HI lan G F 20 |
| Brand: | Synvisc, Synvisc-One |
![]() |
You should not receive hylan G-F 20 if you are allergic to it, or if you have an infection in your knee or in the skin around your knee. |
Before you receive a hylan G-F 20 injection, tell your doctor if you have blood clots or circulation problems in your legs, or an allergy to birds, feathers, or egg products.
For at least 48 hours after your injection, avoid jogging, strenuous activity, high-impact sports, or standing for longer than 1 hour at a time.
![]() |
Call your doctor at once if you have severe pain or swelling around the knee after the injection. |
Hylan G-F 20 is similar to the fluid that surrounds the joints in your body. This fluid acts as a lubricant and shock absorber for the joints.
Hylan G-F 20 is used to treat knee pain caused by osteoarthritis.
Hylan G-F 20 is usually given after other arthritis medications have been tried without successful treatment of symptoms.
Hylan G-F 20 may also be used for purposes not listed in this medication guide.
![]() |
You should not receive hylan G-F 20 if you are allergic to it, or if you have an infection in your knee or in the skin around your knee. |
To make sure you can safely receive hylan G-F 20, tell your doctor if you have:
![]() |
It is not known whether hylan G-F 20 will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. |
![]() |
It is not known whether hylan G-F 20 passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. |
![]() |
Hylan G-F 20 is generally not used in anyone younger than 21 years old. |
Hylan G-F 20 is injected directly into your knee joint. A healthcare provider will give you this injection.
Hylan G-F 20 is usually given once every week for 3 weeks. Follow your doctor's dosing instructions very carefully.
To prevent pain and swelling, your doctor may recommend resting your knee or applying ice for a short time after your injection.
Call your doctor for instructions if you miss an appointment for your hylan G-F 20 injection.
Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
For at least 48 hours after your injection, avoid jogging, strenuous activity, or high-impact sports such as soccer or tennis. Also avoid weight-bearing activity or standing for longer than 1 hour at a time. Ask your doctor how long to wait before you resume these activities.
![]() |
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. |
![]() |
Call your doctor at once if you have severe pain or swelling around the knee after the injection. |
Less serious side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with hylan G-F 20. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 3.01. Revision date: 1/5/2011.
Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by clicking on this link.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @sanfordtimg: #sanfordresearch's Dr. Amy Elliott is filling @keloland in on the CRCAIH Annual Summit http://t.co/brWO1zbKUd